Article
Development of a SETD2-related immune prognostic signature in clear cell renal cell carcinoma.
Medicine - 5 Aug 2022
Wang Xingyuan, Xia Zhinan, Li Zhiyuan, Zhang Cheng
Abstract excerpt
BACKGROUND: Renal cell carcinoma (RCC) is a malignant tumor of urinary system, and clear cell RCC (ccRCC) is the major pathological subtype. A high-frequency mutation in SETD2 gene is related to the occurrence, development, and poor prognosis of RCC. OBJECTIVE: The research of immune-related genes (IRGs) is important to the success of immunotherapy in RCC. The aim of this study was to develop SETD2-related immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
